A transdermal combined contraceptive patch, which contains norelgestromin and ethinyloestradiol. One patch is applied and worn for 1 week to suppress ovulation. Thereafter the patch is replaced on a weekly basis for two further weeks. The fourth week is patch-free to allow a withdrawal bleed.